Asensus Surgical, Inc.
ASXC · AMEX
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 96.5% | -79.3% | 398.7% | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | -25.5% | -182.3% | 19.4% | -163.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,105.7% | -1,531.5% | -295.9% | -1,597.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,166.7% | -2,003.3% | -317.3% | -1,682.1% |
| EPS Diluted | -0.095 | -0.08 | -0.065 | -0.072 |
| % Growth | -18.3% | -22.7% | 8.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |